How Siemens Healthineers’ Optiq AI Imaging Chain Sets a New Benchmark in Image-Guided Therapy

Image-guided procedures in interventional radiology, cardiology, and minimally invasive surgery increasingly involve small and complex anatomies, steep angulations, and patient scenarios such as obesity that traditionally require higher radiation doses. Clinicians frequently face a trade-off between maintaining image clarity and minimizing exposure for both patients and staff. Siemens Healthineers’ Optiq AI imaging chain, introduced at the 2025 RSNA Annual Meeting, addresses this challenge by rethinking how images are formed and optimized before they appear on screen.

AI-Driven Image Quality at Lower Dose
Optiq AI uses a real-time, AI-based denoising algorithm to reduce system-generated noise during image formation. This approach enhances fluoroscopy, acquisition, and digital subtraction angiography by improving sharpness and consistency even in demanding conditions. The technology is designed to support early-stage interventions where clear visualization of small vessels and devices is critical.

Intelligent, Automated Exposure Control
Beyond denoising, Optiq AI differentiates itself through an automated exposure control system trained on extensive procedural data. During image acquisition, the system identifies the optimal combination of tube voltage, current, copper filtration, focal spot size, pulse width, detector dose, and geometric parameters. As the C-arm is moved or angulation and collimation change, the platform continuously recalibrates these settings to preserve the requested image quality while keeping the dose as low as reasonably achievable. This capability reduces manual parameter adjustments and supports more predictable workflows.

Designed for Precision, Speed, and Case Diversity
Optiq AI is available across Siemens Healthineers’ latest interventional platforms: Artis genio, Artis icono.explore, Artis icono.vision, and Artis pheno.vision. These systems cover a broad spectrum of clinical needs, from high-throughput environments to highly demanding cardiac and minimally invasive procedures requiring rapid responsiveness and fine-detail imaging. Early clinical use has shown substantial gains in image clarity, particularly in noise-sensitive scenarios, reinforcing the system’s relevance for complex interventions.

Positioning in a Competitive Landscape
In a market where vendors increasingly incorporate AI into imaging, Optiq AI distinguishes itself by integrating artificial intelligence directly into the image formation pipeline rather than applying post-processing enhancements alone. Its combination of real-time denoising, dynamic exposure control, and fully automated parameter optimization positions it as a next-generation solution aimed at improving both procedural efficiency and diagnostic confidence while limiting radiation exposure.

A Platform for the Next Era of Interventional Care
As minimally invasive therapies expand and require earlier and more precise imaging guidance, Optiq AI provides a pathway to maintain image quality without increasing dose or slowing workflows. Its design supports a broad range of clinical applications and aims to enable consistent, high-quality visualization across a diverse case mix.

www.siemens-healthineers.com